Platinum compound-related ototoxicity in children: long-term follow-up reveals continuous worsening of hearing loss.
Bertolini
Patrizia
P
Pediatric Hematology/Oncology, Azienda Ospedaliera-Universitaria di Parma, Parma, Italy. pbertolini@ao.pr.it
Lassalle
Mathilde
M
Mercier
Guilaine
G
Raquin
Marie Anne
MA
Izzi
Giancarlo
G
Corradini
Nadege
N
Hartmann
Olivier
O
D000293:Adolescent; D000367:Age Factors; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects* / Q000627:therapeutic use; D001299:Audiometry; D016190:Carboplatin / Q000008:administration & dosage / Q000009:adverse effects*; D002648:Child; D002675:Child, Preschool; D002945:Cisplatin / Q000008:administration & dosage / Q000009:adverse effects*; D018450:Disease Progression; D004305:Dose-Response Relationship, Drug; D005260:Female; D005500:Follow-Up Studies; D018072:Hair Cells, Auditory, Outer / Q000187:drug effects; D006319:Hearing Loss, Sensorineural / Q000139:chemically induced* / Q000453:epidemiology; D006801:Humans; D007223:Infant; D008297:Male; D009369:Neoplasms / Q000150:complications / Q000188:drug therapy; D018384:Oxidative Stress; D012189:Retrospective Studies
D016190:Carboplatin; D002945:Cisplatin